Christopher M.Johnson (Chris)

Associate

San Diego + 1.858.314.1185

Connect:

Share

Chris Johnson focuses his practice on high-stakes litigation, dispositive motions, and appeals.

Chris has substantial experience with all facets of litigation, including fact investigation, pleadings, fact and expert discovery, depositions, and motion practice. He has appeared in dozens of cases in federal courts across the country, attending hearings and arguing motions. Chris maintains an active pro bono practice and has represented individuals seeking asylum in U.S. immigration courts, relief in state habeas proceedings, and expungement of their criminal records.

Before joining Jones Day, Chris served as a law clerk on the U.S. Court of Appeals for the Fifth Circuit, where he gained significant legal research and writing experience. Prior to attending law school, he worked in the oil and gas industry as a petroleum engineer.

Experience

  • Merck asserts patent infringement claims under Hatch-Waxman Act relating to Bridion® against 16 generic drug makersJones Day is representing Merck & Co., Inc. in Hatch-Waxman patent infringement actions against 16 generic drug maker defendant groups, relating to the defendant groups' submissions of Abbreviated New Drug Applications to the FDA seeking approval of generic versions of Bridion®, a first-in-class agent for the reversal of certain types of neuromuscular blockade in adults undergoing surgery.
    • View All

    August 2020 Commentary

    Snap Removal After Texas Brine: Considerations for Forum Defendants in the Fifth Circuit

    May 2020 Commentary

    Reboot Required: Artificial Intelligence System Cannot Be Named As An Inventor Under U.S. Patent Law, USPTO Says

    November 2019 Commentary

    When Innovation Creates: Additional Developments in Artificial Intelligence at the U.S. Patent and Trademark Office

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.